{"url_path":"/sec/afjk/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities and Use of Proceeds","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-16","source_url":"https://www.sec.gov/Archives/edgar/data/1979005/0001493152-26-028880-index.html","accession_number":"0001493152-26-028880","cik":"0001979005","ticker":"AFJK","issuer_name":"Aimei Health Technology Co., Ltd.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1979005/0001493152-26-028880-index.html","primary_entity_key":"0001979005","primary_entity_name":"Aimei Health Technology Co., Ltd."},"word_count":523,"has_tables":true,"body_markdown":"Item\n2. Unregistered Sales of Equity Securities and Use of Proceeds\n\n \n\nThe\nfollowing “Use of Proceeds” information relates to the registration statement on Form S-1 (File Number 333-272230), as amended\n(the “Registration Statement”) for our IPO, which was declared effective by the SEC on November 30, 2023. On December 6,\n2023, we consummated our IPO of 6,000,000 units (the “Units”). Each Unit consists of one ordinary share, $0.0001 par value\n(“Ordinary Share”), and one right (“Right”) to receive one-fifth (1/5) of one Ordinary Share upon the consummation\nof an initial business combination. The Units were sold at an offering price of $10.00 per Unit, generating gross proceeds of $60,000,000.\nPursuant to that certain underwriting agreement, dated December 1, 2023, we granted Spartan Capital Securities, LLC, the representative\nof the underwriters, a 45-day option to purchase up to an additional 900,000 Units solely to cover over-allotments, if any (the “Over-Allotment\nOption”). Simultaneously with the consummation of the IPO, the underwriters exercised the Over-Allotment Option in full, generating\ntotal proceeds of $9,000,000.\n\n \n\nSimultaneously\nwith the closing of the IPO on December 6, 2023, we consummated the private placement (“Private Placement”) with Aimei Investment\nLtd. of 332,000 units (the “Private Units”), generating total proceeds of $3,320,000. The Private Units are identical to\nthe Units sold as part of the public Units in this offering. Additionally, Aimei Investment Ltd. agreed not to transfer, assign, or sell\nany of the Private Units or underlying securities (except in limited circumstances, as described in the Registration Statement) until\nthe completion of our initial business combination. Aimei Investment Ltd. was granted certain demand and piggyback registration rights\nin connection with the purchase of the Private Units.\n\n \n\nOn\nDecember 6, 2023, a total of $69,690,000 of the net proceeds from the sale of Units in the IPO and the Private Placement, were placed\nin the Trust Account, located in the U.S. and held as cash items or may be invested in U.S. government securities, within the meaning\nset forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in any open-ended investment company\nthat holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by us,\nuntil the earlier of: (i) the consummation of a business combination or (ii) the distribution of the funds in the Trust Account to our\nshareholders.\n\n \n\nWe\npaid a total of $1,380,000 in underwriting discounts (excluding deferred underwriting discount of $690,000) and $550,000 for other costs\nand expenses related to the IPO.\n\n \n\nAdditionally,\nthe underwriters are entitled to $690,000, equal to 1.0% of the gross proceeds of this offering, payable to the underwriters as deferred\nunderwriting discounts at the closing of our initial business combination from the funds to be placed in the Trust Account. Such funds\nwill be released to the underwriters only upon consummation of an initial business combination, as described in the Registration Statement.\nIf the business combination is not consummated, such deferred discounts will be forfeited by the underwriters. The underwriters will\nnot be entitled to any interest accrued on the deferred underwriting discount."}